Research findings from breast cancer cells indicate that endorepellin is also involved in autophagosomal degradation of HAS2, reducing extracellular hyaluronan in TME, which limits cell proliferation and angiogenesis [48, 49]. This evidence concerns the gene HAS2 and breast carcinoma.